You can buy or sell Edesa Biotech and other stocks, options, ETFs, and crypto commission-free!
Edesa Biotech, Inc. Common Shares, also called Edesa Biotech, is a biopharmaceutical company. Read More It focuses on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company product candidate, EB01, is a sPLA2 inhibitor for the topical treatment of chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness. EB01 employs a novel, non-steroidal mechanism of action and in two clinical studies has demonstrated statistically significant improvement of multiple symptoms in ACD patients. Edesa Biotech was founded in 2007 and is headquartered in Markham, Canada. The listed name for EDSA is Edesa Biotech, Inc. Common Shares.
52 Week High
52 Week Low
— per share
-$0.20 per share